Mega M&A at JP Morgan Conference 2025 — is biopharma M&A poised for a rebound?
Potential antitrust deregulation could foster a more favourable environment for larger M&A deals in 2025, though skepticism remains.
Potential antitrust deregulation could foster a more favourable environment for larger M&A deals in 2025, though skepticism remains.
What's Your Reaction?
